Listing 1 - 10 of 11 | << page >> |
Sort by
|
Choose an application
This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma. .
Medicine & Public Health. --- Hematology. --- Oncology. --- Medicine. --- Médecine --- Hématologie --- Cancérologie --- Medicine --- Health & Biological Sciences --- Pathology --- Oncology . --- Tumors --- Haematology --- Internal medicine --- Blood --- Diseases
Choose an application
This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
Hematology. --- Oncology . --- Oncology. --- Tumors --- Haematology --- Internal medicine --- Blood --- Diseases --- Hodgkin's disease. --- Hodgkin disease --- Hodgkin lymphoma --- Hodgkin's lymphoma --- Lymphadenoma --- Lymphogranuloma --- Lymphogranulomatosis --- Lymphosarcoma --- Pseudoleucemia --- Lymphomas
Choose an application
This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma. .
Oncology. Neoplasms --- Pathological haematology --- oncologie --- hematologie
Choose an application
This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
Oncology. Neoplasms --- Pathological haematology --- oncologie --- hematologie
Choose an application
Choose an application
This book provides a well-illustrated, comprehensive, and up-to-date account of Hodgkin lymphoma. Epidemiology, pathogenesis, and the role of the microenvironment are examined in detail. The initial clinical evaluation and use of staging systems are fully discussed, and prognostic factors are carefully considered. The various treatment options for first-line and relapsed Hodgkin lymphoma are presented, including the newly available treatments for recurrent disease and the management required in special clinical circumstances. Given the very high cure rates and the young age of many patients, there is an increasing need to develop better individually tailored treatment strategies that will help to avoid both early and late side-effects of treatment. Such strategies receive due attention, and clear guidance is provided on the handling of Hodgkin survivors. This book will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
Hodgkin’s disease. --- Lymphoma --- Lymphoproliferative Disorders --- Neoplasms by Histologic Type --- Hodgkin Disease --- Immunoproliferative Disorders --- Neoplasms --- Lymphatic Diseases --- Hemic and Lymphatic Diseases --- Diseases --- Immune System Diseases --- Medicine --- Health & Biological Sciences --- Pathology --- Hematologic Diseases --- Hodgkin's disease. --- Lymphomas. --- Germinoblastomas --- Immunoblastomas --- Non-Hodgkin's lymphoma --- Reticulolymphosarcomas --- Sarcoma, Germinoblastic --- Sarcoma, Immunoblastic --- Hodgkin disease --- Hodgkin lymphoma --- Hodgkin's lymphoma --- Lymphadenoma --- Lymphogranuloma --- Lymphogranulomatosis --- Lymphosarcoma --- Pseudoleucemia --- Medicine. --- Hematology. --- Oncology. --- Medicine & Public Health. --- Lymphoproliferative disorders --- Reticulo-endothelial system --- Lymphomas --- Tumors --- Oncology . --- Haematology --- Internal medicine --- Blood
Choose an application
Oncology. Neoplasms --- Pathological haematology --- oncologie --- hematologie
Choose an application
Oncology. Neoplasms --- Pathological haematology --- oncologie --- hematologie
Choose an application
The renowned authors of this ECFR special volume systematically develop legal standards and regulatory frameworks for closed corporations in Europe (including of course the Societas Privata Europaea), putting a strong focus on the economic practice and efficiency. The profound, in-depth analysis of the objectives and strategies comes to groundbreaking insights and also offers specific solutions for a multitude of practical aspects.
Close corporations. --- Close corporations --- Closed corporations --- Closely held corporations --- Corporation law --- Corporations --- Constructive dividends --- Going private (Securities) --- Law and legislation --- Company Law.
Choose an application
This book provides a well-illustrated, comprehensive, and up-to-date account of Hodgkin lymphoma. Epidemiology, pathogenesis, and the role of the microenvironment are examined in detail. The initial clinical evaluation and use of staging systems are fully discussed, and prognostic factors are carefully considered. The various treatment options for first-line and relapsed Hodgkin lymphoma are presented, including the newly available treatments for recurrent disease and the management required in special clinical circumstances. Given the very high cure rates and the young age of many patients, there is an increasing need to develop better individually tailored treatment strategies that will help to avoid both early and late side-effects of treatment. Such strategies receive due attention, and clear guidance is provided on the handling of Hodgkin survivors. This book will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
Oncology. Neoplasms --- Pathological haematology --- oncologie --- hematologie
Listing 1 - 10 of 11 | << page >> |
Sort by
|